newsfilter
← Latest News
PR Newswire·

Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the second...